for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Global stocks rally on vaccine hopes, crude oil gains

NEW YORK (Reuters) - World shares strode to four-month highs on Wednesday as hopes for a coronavirus vaccine offset rising U.S.-China tensions and also helped lift the euro and oil prices on improved sentiment.

FILE PHOTO: Traders wear masks as they work on the floor of the New York Stock Exchange in response to the outbreak of the coronavirus disease (COVID19) in the Manhattan borough of New York, U.S., May 27, 2020. REUTERS/Lucas Jackson

Asian markets were choppy after more barbs between Beijing and Washington over Hong Kong, but European bourses rose almost 2% and Wall Street advanced as investors set aside concerns about the growing number of COVID cases.

An experimental vaccine produced by biotech start-up Moderna Inc MRNA.O showed it was safe and provoked immune responses in all 45 healthy volunteers, an early- stage trial showed on Tuesday.

A separate University of Oxford trial was also positive news, according to reports on Wednesday.

U.S. Treasury yields rose and the yield curve steepened, indicating a wider spread between long- and short-term interest rates, as the hopes for a vaccine boosted risk appetite and upbeat economic data released on Wednesday added to the optimism.

“The market is trading fairly ‘risk on’ on vaccine hopes,” said Gennadiy Goldberg, an interest rate strategist at TD Securities in New York. “It’s largely COVID news driving the price action recently.”

U.S. industrial production, manufacturing output and plant capacity rose more than expected in June, and there was a bigger- than-expected draw in U.S. crude and refined products last week as demand edges up.

For a graphic on Industrial production:

Adding to the enthusiasm, the Federal Reserve’s Beige Book survey showed U.S. businesses saw an uptick in activity into the beginning of July as states eased restrictions to contain the pandemic.

Europe's broad FTSEurofirst 300 index .FTEU3 rose 1.65%, as growth-sensitive sectors such as travel and leisure .SXTP, miners .SXPP and industrial companies .SXNP led gains.

Moderna surged to a record high after its experimental drug produced high levels of virus-killing antibodies, bolstering hopes it may prove effective in later stages of testing. Moderna shares rose 6.9%.

Goldman Sachs GS.N rose after reporting its trading revenue doubled in the second quarter, driven by big swings in stock and bond markets since March.

On Wall Street, the Dow Jones Industrial Average .DJI rose 0.85%, the S&P 500 .SPX gained 0.91%, and the Nasdaq Composite .IXIC added 0.59%.

Stocks that have benefited from widespread lockdowns, including Amazon.com Inc AMZN.O and Zoom Video Communications Inc ZM.O, slid, limiting Nasdaq's gains. Amazon posted losses for a third consecutive session.

Hopes of progress this week toward a deal on the European Union's 750-billion-euro COVID recovery fund helped sentiment in Europe. The euro traded above $1.1430 EUR= for the first time since March, and Italy and Spain's bond market borrowing costs came down again. [.EU][/FRX][GVD/EUR]

The euro EUR= rose 0.13% to $1.1411. The European Central Bank started a two-day meeting, though no major announcement is expected when it concludes on Thursday.

Chinese shares fell 1.3% .CSI300 and Hong Kong .HSI ended flat after President Donald Trump ordered an end to Hong Kong's special status under U.S. law to punish China for its "oppressive actions" against the former British colony.

China’s Foreign Ministry vowed to retaliate, saying, “Hong Kong affairs are purely China’s internal affairs and no foreign country has the right to interfere.”

Japan's Nikkei .N225 and Australia's benchmark index remained upbeat, finishing up 1.6% and 1.9%, respectively.

For a graphic on Bulls in the China shop:

RED ALERT

The dollar was on the defensive, particularly against risk-sensitive currencies, following the news of progress in vaccine development. [/FRX]

Sweden's crown SEK= vaulted to its highest versus the greenback since February 2019 and the risk-sensitive Australian dollar popped to a one-month high at $0.70 AUD=D4.

The yen JPY= was down 0.27% at $106.9400.

Oil rose on the sharp drop in U.S. inventories, but further gains were limited as the Organization of the Petroleum Exporting Countries and allies were set to ease supply curbs from August as the global economy recovers from the pandemic.

Brent crude LCOc1 settled up 89 cents at $43.79 a barrel, while U.S. crude CLc1 rose 91 cents to settle at $41.20 a barrel.

Gold prices held above $1,800 an ounce as the surge in coronavirus cases and renewed U.S.-China tensions bolstered safe-haven demand, but the rally in stocks capped the advance.

U.S. gold futures GCv1 added 40 cents to settle at$1,813.80. Spot gold XAU= rose 0.15% to $1,810.17.

Yields on the 10-year U.S. Treasury note US10YT=RR rose 1.9 basis points to 0.6332%.

Reporting by Marc Jones and Herbert Lash; additional reporting by Karen Brettell in New York; Editing by Steve Orlofsky, Richard Chang and Leslie Adler

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up